CLINICAL_TRIALS
trial_result
· 2015-06-22
Clinical Trial Update: Tapentadol in Chronic Malignant Tumour Related Pain [Phase 3]
Summary
Phase 3 trial for tapentadol in cancer-related chronic malignant tumour pain was terminated; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Grünenthal GmbH | Conditions: Cancer, Chronic Pain | Phase 3 | Status: TERMINATED | Results posted: 2015-06-22